Clinical Trial Update: A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough [Phase 2]

View source ↗

Summary

Phase 2 study evaluating XEN-D0501 for reducing cough frequency in chronic idiopathic cough has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Cough

Drugs mentioned

• XEN-D0501

Snippet

Sponsor: Xention Ltd | Conditions: Chronic Idiopathic Cough | Phase 2 | Status: COMPLETED